Re-Inventing Immunotherapy - Building on Induction of Tolerance

We create novel immunotherapies for allergy and autoimmune diseases

Our Concept & Patent-protected Technologies

Basic Concept: Peripheral immune modulation - Systemic tolerance

Hydrogel & Liposomes

We are developing efficient systems for drug delivery

Focus on regulatory T-cells

We aim at utilizing natural tolerance pathways

Small molecule immune modulators

Immune cell attraction and modulation

Recombinant immune modulators

Specific and effective modulation

Recombinant allergens

Component-resolved diagnosis & efficient immunotherapy

Our Management

Leo W. Tristram

CEO / CFO

Mr. Tristram has over 25 years of experience in the bio-pharmaceutical industry. Key areas of responsibility have included Business Development and Strategic Planning, both in early-stage and larger company settings. He has very relevant experience in setting up and financing new companies. He holds an MBA from the Ludwig-Maximilians-Universität München as well as diplomas in Economics and Legal Affairs. Former positions include senior management positions at Texas Instruments Inc. and OTTO Versand GmbH & Co. Mr. Tristram is co-founder of PLS-Design GmbH and leads the company as CEO and CFO.

Contact Leo W. Tristram

Prof. Dr. med. Reinhard Bredehorst

CSO

Prof. Bredehorst has over 20 years of experience in the bio-pharmaceutical industry. Key areas of responsibility have included the development of novel concepts for the treatment of allergic diseases and appropriate patent protection of such concepts. Prof. Bredehorst is co-founder of PLS-Design GmbH and since 2004 CSO of the company. Following academic positions at the University Hospital Hamburg Eppendorf and Georgetown University (Washington DC), since 1995 he is Professor of Biochemistry and Molecular Biology at the University of Hamburg. Prof. Bredehorst is board certified for Clinical Chemistry and Clinical Biochemistry.

Contact Reinhard Bredehorst